INTRODUCTION
A well-documented long-term action of insulin is to downregulate its cell-surface receptors [1] [2] [3] [4] [5] . This process appears to involve two steps; receptor internalization followed by a slower phase of degradation [4, 5] . The regulation mechanism of these events is not known. The appreciation that insulin-receptor autophosphorylation and its activation as a tyrosine-specific protein kinase is an essential step in mediating a number of insulin's biological effects has led to the hypothesis that these same biochemical events are necessary for insulin-mediated receptor down-regulation. Studies of transfected insulin receptors mutated at Lys-1018 (numbering according to Ullrich et al. [6] ), a critical amino-acid residue involved in ATP binding, revealed that defects in autophosphorylation and tyrosine kinase activity were associated with an inability of insulin to stimulate receptor endocytosis and down-regulation [7] [8] [9] . In the study in which arginine [9] rather that alanine [7, 8] was substituted for lysine, the mutant insulin receptors did undergo constitutive internalization, raising the possibility that this first step in downregulation may not always be receptor-kinase-dependent. Similar conflicting results have been published for the epidermal growth factor (EGF)+ receptor. Thus, tyrosine kinase-defective EGF receptors did not undergo EGF-dependent internalization and down-regulation [10, 11] . Also, micro-injected monoclonal antiphosphotyrosine antibodies inhibited EGF-dependent internalization of native EGF receptors [11] . In contrast, other tyrosine kinase-deficient mutant EGF receptors did undergo liganddependent internalization, but not receptor degradation [12, 13] .
pre-exposure to a high concentration of PMA (1 ,uM) , which is known to inactivate PKC, blocked the effect of PMA. PMA inhibited insulin-stimulated receptor internalization by 26 % and receptor degradation by 820%. Exposure of intact cells to PMA followed by insulin treatment inhibited insulin-receptor autophosphorylation subsequently assayed in vitro, as well as ,f-subunit tyrosine phosphorylation in situ. In summary, PMA inhibited insulin-stimulated receptor down-regulation via activation of PKC. This was associated with an inhibition of both receptor internalization and receptor degradation. There was a concomitant inhibition of receptor tyrosine autophosphorylation consistent with a requirement of receptor kinase activation for both short-term and long-term biological effects of insulin.
Overall, the evidence that receptor tyrosine kinase activity is required for receptor degradation is stronger than that for internalization.
Phorbol esters are known to bind to and activate protein kinase C (PKC), a Ca2+-and phospholipid-dependent serine/ threonine kinase [14, 15] . Phorbol esters cause a rapid decrease in insulin binding in several cell types [16] [17] [18] . This has been associated with a decrease in receptor affinity in cultured human lymphocytes [16] and adipocytes [17] , but enhanced receptor internalization in endothelial cells [18] . Similar effects of phorbol esters have been reported for insulin-like growth factor (IGF-1) [19] , EGF [20] , transferrin [21] , and asialoglycoprotein [22] receptors. In Fao cells no acute effect on insulin binding was found [23] . Apart from these variable effects on binding, phorbol esters have been shown to induce insulin resistance to rat adipocytes [17, 24] and Fao hepatoma cells [23, 25] . Thus, phorbol 12-myristate 13-acetate (PMA) inhibited insulin-stimulated glucose transport in adipocytes, and glycogen synthase and tyrosine aminotransferase activities in hepatoma cells. Other studies demonstrated that phorbol esters stimulate insulin-receptor phosphorylation on serine residues in intact cells [18, 25, 26] . Such phosphorylation has been observed directly by PKC in vitro [27] . This phosphorylation was associated with an impairment of insulin-stimulated receptor-tyrosine-kinase activity [24, 25] . Thus, it was postulated that the insulin resistance induced by phorbol esters is mediated by PKC-stimulated phosphorylation of the insulin receptor.
In this study we examined the relationship between insulinreceptor autophosphorylation and insulin-induced receptor down-regulation in cultured human lymphocytes. We 
Cell culture
Human lymphocytes (IM-9) were cultured in RPMI-1640 supplemented with 25 mM Hepes and 10 % (v/v) FBS at 37°C in a humidified atmosphere of 5 % CO2 and air as described in [28] . Cells in late logarithmic phase were harvested by centrifugation (10 min at 500 g) and washed twice with PBS. They were resuspended in fresh medium containing pig insulin, PMA, or combinations at the concentrations indicated. After 18 h, or the times indicated at 37°C, the cells were harvested and washed three times over a period of 60 min at 22°C in PBS (pH 7.4) containing 1 % (w/v) BSA to remove residual insulin [28] . Cell viability determined by Trypan Blue exclusion was always equal in control and treated cells and greater than 85 %.
[3H]PDBU binding to IM-9 lymphocytes After washing, cells were resuspended in RPMI-1640 and [3H]PDBU binding was performed as described in [29] . Cells (15 x 106 cells/ml) were incubated with 5 nM [3H]PDBU with shaking in the presence ofincreasing concentrations of unlabelled phorbol ester or its analogues for 120 min at 4°C in a total volume of 500,ul. The assay was terminated by diluting the incubation mixture with 3 ml of ice-cold PBS. Cells were recovered on glass fibre filters by filtration and washed three times with 3 ml of ice-cold PBS. The filters were placed in scintillation vials and 0.5 ml of Protosol and 5 ml of Econofluor were added sequentially. Vial contents were mixed and radioactivity was determined in an LKB ,-counter after 18 [28] . Cells (8 x 106 cells/ml) were incubated with 1251-insulin (0.1 ng/ml), iodinated by the chloramine-T method to 200 Ci/g [28] , and 0-100000 ng/ml of unlabelled insulin for 90 min at 15°C in a total volume of 500 la1. (50,tl) were incubated for 20 h at 4°C with "25I-insulin (0.1 ng/ml) in binding buffer (150 mM NaCl/50 mM Hepes/lO mM MgSO4/0. 15 % BSA) pH 7.6, with and without 0.1-1000 ng/ml of unlabelled insulin in a total volume of 0.5 ml.
The final Triton X-100 concentration in the assay was 0.016 0%.
The assay was terminated by addition of 1 ml of 0.1250 rabbit y-globulin and 1.0 ml of 25 % (w/v) poly(ethylene glycol), both dissolved in 50 mM Hepes (pH 7.6), followed by centrifugation at 2000 g for 30 min. The supernatants were aspirated and the radioactivity of the pellets was counted. Non-specific binding was designated as binding in the presence of 1 ,ug/ml insulin and subtracted from total binding to yield specific binding. Results were corrected for 100 jug of protein determined by the Bio-Rad assay [30] and expressed as mean+ S.E.M. lodination of cell-surface proteins Labelling of cell-surface proteins was performed using the lactoperoxidase technique [31] modified by Taylor and MarcusSamuels [32] as wc described in [33] . Cells were washed three times in Dulbecco's PBS without Ca2 and Mg"+ and resuspended (2 x 107 cells/ml) in the same buffer containing 20 mM glucose at room temperature. Lactoperoxidase (25 ,tg/ml) was added to the cell suspension with constant stirring. The reaction was started by the addition of glucose oxidase (100 munits/ml) and Na"2'I (100 ,uCi/ml). The reaction was stopped by dilution into Dulbecco's PBS lacking Ca2 and Mg2+ (106 cells/ml). The suspension was centrifuged at 500 g for O min, the supernatant was discarded, and the cells were washed three times with the abovementioned buffer. They were resuspended in culture medium and incubated at 37°C for 60 min before additions were made. At the times indicated after additions of PMA and/or insulin, cells were harvested by centrifugation and solubilized in 3 ml of ice-cold buffer as described above. An aliquot ofthe 100 000 g supernatant was assayed for protein content using the Bio-Rad reagent and the remainder was used for immunoprecipitation.
Before immunoprecipitation Triton X-100 present in the solubilization buffer was removed by shaking the 100000 g supernatant in the presence of Bio-Beads SM-2 for 6 h [34] .
Immunoprecipitatlon of receptors
Protein A-Sepharose-affinity-column-purified anti-(insulin receptor) antibody (14 mg/ml) was added to solubilized receptors (0.9 ml) and incubated, with shaking, at 4°C for 16 h. Pansorbin [200 ,l# of a 10 % (w/v) suspension] was added and the incubation was continued for 4 h at 4 'C. The immunoprecipitates were centrifuged (500 g, 5 min) and washed [2 x 900,l of 50 mM Hepes (pH 7.6)/0.1 % Triton X-100; 1 x 900 ,ul of 50 mM Hepes (pH 7.6)/0.1 % SDS/0.1 % Triton X-100; 1 x 900 ,ul of 50 mM Hepes (pH 7.6)/0.1 % Triton X-100] and subjected to SDS/ PAGE in a 7.5 % (w/v) gel. The gel was stained with Coomassie Brilliant Blue, destained, soaked in Amplify fluorography reagent, and dried. The driel del was exposed on Kodak X-Omat AR film for 1 week at -80 'C, and labelled proteins were detected by autoradiography and quantified by densitometry. Densitometric values with individual variances (expressed as percentages of radioactivity remaining in the insulin-receptor a-subunit) were fitted using an exponential function with the Multifit non-linear regression software (version 2.01) from Day Computing (Cambridge, U.K.).
Partial receptor purification
The 100000 g supernatant, after cell solubilization, was applied to a column (0.6 cm x 3.0 cm) of WGA-agarose and after washing with 100 ml of 50 mM Hepes buffer, pH 7.6, containing 150 mM NaCl and 0.1 0% Triton X-100, the bound material was eluted with the above buffer supplemented with 0.3 M N-acetyl-D-glucosamine.
Insulin-receptor autophosphorylation Aliquots (30-50 ,u) was apparent at all insulin concentrations (Figure 3a ). When the two curves were normalized to their respective tracer binding values, they were superimposable (Figure 3b ). These results indicated that apparent receptor affinity (IC50 = 9.0 ng/mI insulin) remained unchanged and that short-term PMA treatment resulted in a decrease in the number of cell-surface insulin receptors.
Chronic effects of PMA on insulin binding
To determine the long-term effects of PMA, cells in culture were exposed to various concentrations of PMA for 18 h at 37°C after which cells were washed and '25I-insulin binding was assayed.
There was no effect of PMA on insulin binding after 18 h exposure, indicating that the acute effect was transient (Figure 4 ). To determine whether chronic exposure to PMA affected insulin-stimulated down-regulation of its own receptor, cells were co-incubated with insulin (10-7 M) and various concentrations of PMA. Insulin alone decreased numbers of cell-surface receptors by 64.8 % after 18 h at 37 'C. Low concentrations of PMA (2-50 nM) inhibited the insulin-induced down-regulation significantly (Figure 4 ). In the presence of 5 nM PMA, insulin binding was decreased in the presence of 10-7 M insulin by only 49.7+4%. (P < 0.05). This represented a 23.30% inhibition of insulin-induced down-regulation. When a high concentration of PMA (1 ,uM) was used, there was no effect on insulin-induced down-regulation (Figure 4 ). An inactive phorbol ester analogue, a-PDD, also did not inhibit insulin-induced down-regulation (results not shown).
PMA inhibits the insulin-induced decrease in total cellular receptors
The total complement of cellular insulin receptors was assessed to determine the effect of PMA on insulin-receptor metabolism. After incubation of cells in the presence and absence of insulin and PMA for 18 h as described above, lymphocytes were homogenized and solubilized in Triton X-100 and 1251-insulin binding determined as described in the Experimental section. Insulin binding to total cellular solubilized receptors showed that 10-' M insulin decreased specific binding to 30.2 + 7.5 % of control (mean+s.E.M., n = 3). PMA (5 nM) alone had no effect To determine whether this effect on insulin binding may have been mediated by an alteration in receptor affinity, complete competition-binding curves were generated after incubation for 20 h in the presence and absence of 2.5 nM PMA and/or 10-8 M insulin. The competition-binding curves and Scatchard plots [36] indicate that PMA inhibited the decrease in total cellular insulinreceptor number induced by insulin ( Figure 5 ).
Inhibition of the PMA effect by sphingosine Sphingosine, a phospholipid commonly found in membranes, has been shown to be a potent inhibitor of PKC and a phorbol ester antagonist [37] . To confirm that the PMA effect was mediated by PKC, cells were treated for 18 h with sphingosine (10 juM) alone, sphingosine in the presence of insulin (10-v M), and sphingosine with insulin (10-' M) plus PMA (5 nM). In the presence of sphingosine insulin was able to down-regulate total cellular insulin receptors to the same extent in the absence and presence of PMA (ratio of bound/free 1251-insulin; sphingosine alone 0.094, sphingosine and insulin 0.050, sphingosine and insulin plus PMA 0.049). In these experiments the effect of PMA on inhibition of insulin-induced receptor down-regulation in the absence of sphingosine was similar to that indicated above.
Effect of PMA on Insulin-induced receptor Internalization
Experiments in 3T3C2 fibroblasts [4] , rat adipocytes [5] and our previous results in IM-9 lymphocytes [33] showed that insulinstimulated down-regulation involves two steps, receptor internalization followed by a slower phase-of degradation. The ability of insulin to induce internalization was assessed by exposing cells to insulin at 37°C for 1 h. This was followed by a cold acid wash to remove residual insulin. We demonstrated previously that under these conditions the loss of insulin binding to intact cells is completely recoverable upon cell solubilization [33] . 
PMA Inhibits insulin-induced receptor degradation
To assess the phase of receptor degradation cells were surfacelabelled with 1251 and treated with PMA, insulin, PMA plus insulin, or vehicle alone for various times, solubilized, and the insulin receptors immunoprecipitated and separated by SDS/ PAGE as described in the Experimental section. Insulin ( Figure  6 , lanes 3, 6, 9 and 12) accelerated the degradation of the surface-labelled receptors compared with control levels ( Figure  6 , lanes 1, 2, 5, 8 and 11). This effect was clearly inhibited by PMA ( Figure 6 , lanes 4, 7, 10 and 13). The half-life of the asubunit of the insulin receptor was determined from the densitometric analysis of autoradiographs of gels at times 4-20 h. In the presence of 10-v M insulin the amount of 1251-labelled insulin receptor was significantly decreased at each time point ( Figure  7b ). Receptor half-life (ti) was shortened by 51 % from 8.1 h to 4.0 h, consistent with previous studies [3, 32, 33] . PMA alone (5 nM) decreased insulin receptor t1 from 8.1 to 6.9 h, reflecting a small increase in the rate of degradation (Figure 7a ). However, in the presence of PMA, the effect of insulin on receptor degradation was severely inhibited (6.9 h to 6.3 h) (Figure 7c ).
Effect of PMA on Insulin-receptor autophosphorylation
Since the inhibitory effects of PMA on insulin action have been associated previously with a defect in insulin-receptor autophosphorylation [24, 25] , we determined the effect of PMA on autophosphorylation in these cultured IM-9 lymphocytes.
Cells were incubated at 37°C in the absence and presence of PMA (5 nM or 100 nM) for 30 min, followed by the addition of insulin (10-7 M) partially purified insulin receptor. To confirm that this inhibitory effect of PMA was associated with diminished insulin stimulation of receptor tyrosine autophosphorylation in the intact cells, the isolated receptors were separated by SDS/PAGE, transferred to nitrocellulose membranes and blotted with both anti-(phosphotyrosine) and anti-(fl-subunit) antibodies. Pre-exposure to PMA for 30 min inhibited the response to insulin of in situ phosphotyrosine incorporation in parallel to the inhibition of autophosphorylation observed above (Figure 8b ). Autoradiographs from three to seven separate lactoperoxidase-labelling experiments as Short-term exposure of cultured human lymphocytes [16] , U-937 described in Figure 6 were scanned and densitometric readings were plotted as mean + S.E.M. monocytes [16] and adipocytes [17] plus 5nM PMA, < t=6.3h (A). Statistical significance: 'P<0.05; <0.005; [20, 38] , transferrin [21, 22] , tumour necrosis factor-a [39] and low-density lipoprotein [40] phorbol esters induce a rapid, dosedependent decrease in cell-surface insulin receptor number. In the case of the insulin receptor it has been reported that in some cells internalization of only the hormone-occupied receptor but described in the Experimental section. PMA alone had no effect not that of the unoccupied receptor is increased by PMA [41] .
on total insulin-receptor phosphorylation. However, there was a
The effect of PMA may depend on the localization of receptors dose-dependent inhibition of in situ insulin activation of autoin coated pits. Thus, under our cell-culture conditions, a fraction phosphorylation by pre-exposure of cells to PMA. (Figure 8a ).
( dependent serine/threonine kinase, PKC. PMA stimulates insulin-receptor serine phosphorylation in these [26, 43] and other cell types [18, 25] . Whether the PMA-stimulated internalization is mediated via insulin-receptor phosphorylation is not clear. Two lines of evidence raise questions about this possible mechanism. First, studies with a mutated transferrin receptor indicated that PMA could exert its effect on receptor movement despite substitution of the serine residue (Ser-24), which is phosphorylated, for alanine [44] . Secondly, in Fao hepatoma cells, PMAstimulated insulin-receptor phosphorylation was not associated with any change in insulin binding [23, 25] . In adipocytes and Fao hepatoma cells, exposure to PMA has been associated with resistance to acute biological effects of insulin [17, 23] . In this study, we found that PMA induced resistance to a long-term effect of insulin, i.e. down-regulation of its own receptor. In the presence of PMA, insulin-stimulated down-regulation of cell-surface receptors was inhibited by 23 %.
At a concentration of 1 ,um, PMA did not inhibit receptor down-regulation. It is known that exposure to high concentrations of PMA for a prolonged time results in down-regulation and degradation of PKC in a variety of cell types [45] . After such treatment cells become resistant to the actions of phorbol esters which are mediated via PKC activation [46, 47] . Thus, the absence of an inhibitory effect on insulin-receptor down-regulation at this high PMA concentration suggests that the PMA effect was mediated by activation of PKC. The blockade of the PMA effect in the presence of 10 4uM sphingosine further supports the interpretation that PKC is the putative mediator of the inhibitory effect of PMA on insulin-receptor down-regulation.
PMA inhibited the early phase (1 h) of disappearance of surface receptor by 26 %, similar to the extent of inhibition of down-regulation assessed by insulin binding to intact cells. The extent of internalization at 1 h reflects a steady state between the rates of endocytocis and recycling. We have not determined whether either rate is altered. However, the lack of internalization of tyrosine kinase-defective mutant receptors [7, 8] suggests the possibility that neither rate may be affected, but that a population of receptors which are inhibited by PMA is generated which do not internalize at all.
The results observed with solubilized receptors suggested that the effect of PMA was not confined to receptor internalization. Indeed, PMA inhibited the effect of insulin on stimulation of insulin-receptor degradation. The transient nature of the decrease in cell-surface insulin receptors induced by PMA indicates that the short-term decrease in receptor availability could not account for these long-term effects of PMA. A possible mechanism of the inhibitory effect of PMA was suggested by studies in which mutated tyrosine kinase-defective insulin receptors could not be stimulated by insulin to undergo down-regulation [7, 8] . Thus, the inhibitory effect of the phorbol ester could be mediated via an inhibition of insulin-receptor autophosphorylation. Pre-exposure of intact cells to 5 nM PMA inhibited insulin activation of receptor autophosphorylation assayed in vitro. Furthermore, PMA inhibited insulin stimulation of insulin-receptor tyrosine phosphorylation in situ. These results are in agreement with previous results obtained in these and other cell types [25, 27] . However, it should be noted that inhibition of insulin-stimulated insulin-receptor autophosphorylation by PMA has not been consistently observed by all investigators [43] .
Recently, Lewis et al. demonstrated that Thr-1336 in the Cterminal region of the f-subunit is the major amino-acid residue phosphorylated in response to PMA in vitro [48] . In situ stimulation by PMA led to similar phosphorylation, as well as the appearance of additional serine-phosphorylated peptides [48] . The relationship of the receptor kinase inhibitory effect of PMA Anderson and Olefsky demonstrated that PMA inhibited insulinstimulated receptor autophosphorylation, tyrosine kinase activity and glucose incorporation into glycogen in Rat-l fibroblasts expressing a 43 amino-acid C-terminal-truncated receptor [49] . The mechanism of the PMA effect remains to be determined.
Thies et al. have recently defined a submembrane region of the insulin receptor encoded by exon 16 which is necessary but not sufficient for insulin-induced internalization [50] . The activation of the receptor tyrosine kinase has also been demonstrated to be required [51] . However, Backer et al. reported that depletion of cellular ATP resulted in a decrease of insulin-stimulated receptor autophosphorylation but did not affect internalization [52] . There is strong support for the hypothesis that the second phase of the down-regulation process, i.e. receptor degradation, is tyrosine kinase dependent. Thus, mutagenesis studies uniformly indicate defective insulin-induced down-regulation of tyrosine kinasedefective receptors, even with a Lys to Arg-1018 mutant, which undergoes constitutive internalization [9] . Furthermore, Marshall and Monzon have demonstrated [53] , and we have confirmed (C. Walker and I. G. Fantus, unpublished work), that vanadate, a protein tyrosyl phosphatase inhibitor which mimics insulin in adipocytes, can induce ligand-independent insulin-receptor degradation. The results in this study are consistent with the requirement of insulin-stimulated receptor autophosphorylation for both phases of down-regulation.
The observation that insulin-induced down-regulation of its own receptor was normal after exposure to high concentrations of PMA indicates that PKC is not involved in this action of insulin. Similarly, EGF-mediated down-regulation of its receptor does not require PKC-mediated receptor phosphorylation [38] . There is still controversy regarding the potential role of PKC in other actions of insulin [47, [54] [55] [56] and whether high concentrations of PMA can completely remove PKC [56, 57] . The normal extent of insulin-receptor down-regulation during chronic exposure to high PMA concentrations, as well as in the presence of sphingosine, lends support to the view that PKC is not involved.
In summary, this study demonstrates that PMA inhibits insulin-stimulated down-regulation of its own receptor. The disappearance of the effect at high PMA concentrations and inhibition by sphingosine are consistent with activation of PKC. The inhibition involves both receptor internalization and degradation. At the same concentrations PMA also inhibited insulinstimulated insulin-receptor tyrosine autophosphorylation. Taken together, these results strongly support the results from mutagenesis studies that insulin-receptor autophosphorylation is a requirement for insulin-induced receptor internalization and degradation.
